https://www.fool.com/investing/2018/11/11/how-bristol-myers-squibb-company-fell-188-billion.aspx
A failed clinical trial doesn't bode well for the big pharma's lung cancer strategy.
bristol myers squibbcompanyfellbillion
https://www.prnewswire.com/news-releases/11-years-of-global-patient-week-bristol-myers-squibb-brings-joy-to-patients-with-toy-making-workshops-across-the-region-302583204.html
/PRNewswire/ -- Underscoring its unwavering commitment to patient-centricity, Bristol Myers Squibb, a leading global biopharmaceutical company, marked the...
bristol myers squibbyearsglobalpatientweek
https://www.bms.com/life-and-science/patients/advancing-alzheimers-patient-advocacy.html
Oct 1, 2025 - Hear from Jim and Geri on their journey with Alzheimer’s disease, their efforts in advancing patient advocacy, and dedication to future generations.
bristol myers squibbpatient advocacyjimstory
https://www.bms.com/researchers-and-partners/areas-of-focus.html
Bristol Myers Squibb focuses on core therapeutic areas such as oncology, along with multiple drug platforms across these areas, to transform patients' lives...
research and developmentbristol myers squibbareasfocus
https://blog.google/products-and-platforms/devices/fitbit/bristol-myers-squibb-pfizer-alliance-and-fitbit-collaborate/
Leaders in atrial fibrillation and wearable technology work together to develop content around AFib to help identify and support those at increased risk of...
bristol myers squibbpfizeralliancefitbitcollaborate
https://www.foxbusiness.com/features/bristol-myers-shares-hammered-on-insider-trading-arrest-hepatitis-trial-halt
Bristol-Myers Squibb shares slumped 8% after the drug maker halted a hepatitis C trial and U.S. officials arrested executive Robert Ramnarine on insider...
bristol myersinsider tradingshareshammeredarrest
https://www.bms.com/patient-and-caregivers/patient-resources-by-condition/immunology-resources.html
At Bristol Myers Squibb, we are working to deliver meaningful solutions that address unmet needs in rheumatology, gastroenterology, dermatology and neurology....
bristol myers squibbimmunologypatientresources
https://www.drugdiscoverytrends.com/2023-pharma50/bristol-myers-squibb/
May 23, 2023 - Bristol Myers Squibb has a new product portfolio could achieve $25 billion of non-risk-adjusted revenue by the end of the decade.
bristol myers squibbdrug discoverydevelopment
https://www.bms.com/pe/pharmacovigilance.html
Learn more about the terms and conditions of the Bristol Myers Squibb website and information.
bristol myers squibb
https://www.businesswire.com/news/home/20220512006132/en/LOTTE-to-Purchase-Bristol-Myers-Squibb-Manufacturing-Facility-in-East-Syracuse-New-York
LOTTE to Purchase Bristol Myers Squibb Manufacturing Facility in East Syracuse, New York
bristol myers squibblottepurchasemanufacturingfacility
https://www.bms.com/business-development/science-and-technology-areas-of-interest.html
BMS is focused on core therapeutic areas and multiple drug platforms to transform patients' lives through science and technology. Learn more about our areas of...
bristol myers squibbareasinterest
https://www.bms.com/be/nl/unpublished-pages/oncologie.html
Kom meer te weten over wat wij doen binnen oncologie en hoe wij inzetten op innovatieve geneesmiddelen voor de behandeling van kanker.
bristol myers squibb
https://www.news-medical.net/news/20100303/AGN-209323-small-molecule-for-neuropathic-pain-Bristol-Myers-Squibb-Allergan-announce-global-agreement.aspx
Bristol-Myers Squibb Company and Allergan, Inc. today announced a global agreement for the development and commercialization of AGN-209323, a Phase II-ready,...
bristol myers squibbsmall moleculeneuropathic painagn
https://www.finanznachrichten.de/nachrichten-2026-01/67499889-bristol-myers-squibb-company-bristol-myers-squibb-announces-collaboration-with-microsoft-to-advance-ai-driven-early-detection-of-lung-cancer-200.htm
Joint initiative to focus on expanding early detection and equitable access to care through lung cancer specific AI workflows on Microsoft's suite of radiology...
bristol myers squibbcompanyannouncescollaboration
https://www.bms.com/life-and-science/news-and-perspectives/all-kids-with-cancer-deserve-a-fighting-chance.html
Bristol Myers Squibb's goal regarding pediatric cancer is that no child - anywhere in the world - should die from cancer. But at a minimum, all children should...
a fighting chancebristol myerskidscancerdeserve
https://www.bms.com/life-and-science.html
Beyond just relevant information about Bristol Myers Squibb's therapeutic areas and scientific innovation, Our stories offers a window into the work our...
bristol myers squibbstories
https://www.bms.com/pe/patient-and-caregivers.html
En Bristol Myers Squibb buscamos mejorar la vida de los pacientes ofreciendo recursos y programas, tanto para los pacientes como para sus cuidadores. Explore...
bristol myers squibbpacientes
https://www.biospace.com/bristol-myers-squibb-presents-updated-efficacy-data-from-phase-2-trial-of-empliciti-elotuzumab-plus-pomalidomide-and-dexamethasone-in-patients-with-relapsed-or-refractory-multiple-myeloma-rrmm
Bristol-Myers Squibb Company announced the presentation of updated data from ELOQUENT-3, the international randomized Phase 2 study evaluating Empliciti plus...
bristol myers squibbpresentsupdatedefficacydata
https://www.bms.com/gb/researchers-and-partners.html
Our research pipeline is the result of passionate discovery efforts & innovative partnerships. Read more about our research & partners!
bristol myers squibbresearcherspartners
https://www.bms.com/ie/patient-and-caregivers.html
At Bristol Myers Squibb, we seek to improve the lives of patients by offering resources & programs for both patients & caregivers. Explore our resources today.
bristol myers squibbpatientscaregivers
https://www.fiercebiotech.com/biotech/bms-new-safety-data-psoriasis-drug-puts-company-track-third-new-drug-launch-2022
Bristol Myers Squibb just released new two-year deucravacitinib data showing lasting efficacy for patients with moderate to severe plaque psoriasis.
bristol myerson tracknew druglaunch
https://www.ey.com/en_us/insights/strategy-transactions/cash-leadership-office-for-bristol-myers-squibb
EY-Parthenon team helped BMS establish a cash leadership office as part of an award-winning Treasury transformation. Learn more in this case study.
bristol myers squibbcashleadershipofficeey
https://www.bms.com/investors/stock-information/dividend-history.html
Find the dividend history information for BMY stock including payable date, record date, amount and dividend type from 1970 until present.
bristol myers squibbdividendhistory
https://www.biospace.com/bristol-myers-squibb-company-grants-help-k-12-educators-bring-science-to-life-and-help-students-explore-their-interests-in-the-sciences-and-science-ba
bristol myers squibbcompanygrantshelpk
https://www.bms.com/media/media-library/disease-state-infographics.html
Bristol Myers Squibb shares a series of infographics to view statistics, illustrate key facts and provide information on different cancers and disease types.
bristol myers squibbdisease stateresources
https://www.prnewswire.com/news-releases/archerdx-enters-collaboration-with-bristol-myers-squibb-to-apply-personalized-cancer-monitoring-pcm-to-clinical-research-301079413.html
/PRNewswire/ -- ArcherDX, Inc. today announced it is entering into a collaboration with Bristol Myers Squibb (BMS) to utilize Personalized Cancer Monitoring...
bristol myers squibbenterscollaborationapplypersonalized
https://www.marketscreener.com/news/bristol-myers-squibb-announces-positive-topline-results-from-phase-3-scout-hcm-trial-evaluating-camz-ce7e58dad089f622
Bristol Myers Squibb announced positive topline results from SCOUT-HCM, a Phase 3 trial evaluating Camzyos in the first study of a cardiac myosin inhibitor in...
bristol myers squibbannouncespositivetoplineresults
https://www.marketscreener.com/quote/stock/BRISTOL-MYERS-SQUIBB-COMP-11877/company-shareholders/
Find the distribution by types of shareholders of Bristol-Myers Squibb Company listed on the Nyse stock exchange. Discover the geographical origin of the...
bristol myers squibbcompanyshareholdersshareholdingstructure
https://www.bms.com/business-development/existing-partners.html
Bristol Myers Squibb’s collaborative partnerships are critical to our ability to provide transformative medicines to patients. Explore our strategic...
bristol myers squibbpartnerships
https://www.prnewswire.com/news-releases/bristol-myers-squibbs-michael-l-ryan-elected-national-pharmaceutical-council-board-chair-301171567.html
/PRNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Michael L. Ryan, PharmD, Senior Vice President, Worldwide Value, Access,...
bristol myers squibbmichaelryanelectednational
https://www.bms.com/about-us/our-company/history-timeline.html
Bristol Myers Squibb has been striving hard to improve lives by providing better healthcare solutions since the early 1800s. Learn more about our company's...
bristol myers squibbcompany historytimeline
https://www.bms.com/life-and-science/news-and-perspectives/who-i-am-working-for-and-why-it-drives-me-every-day.html
Sep 27, 2025 - Chris, a biopharma leader from Arkansas with a PhD from UC Berkeley, now leads at Bristol Myers Squibb, driving bold science and patient impact.
workingdrives
https://www.bms.com/business-development/why-partner-with-us.html
The Alliance Management team facilitates effective relationships between Bristol Myers Squibb and our key partners and stakeholders. Learn more!
partner with usbristol myers squibb
https://www.macrotrends.net/stocks/charts/BMY/bristol-myers-squibb/net-income
Bristol Myers Squibb annual/quarterly net income history and growth rate from 2012 to 2025. Net income can be defined as company's net profit or loss after all...
bristol myers squibbnet incomebmy
https://www.marketscreener.com/quote/stock/BRISTOL-MYERS-SQUIBB-COMP-11877/graphics-comparison/
Bristol-Myers Squibb Company: Historical stock chart comparison, Stock Bristol-Myers Squibb Company | BMY | US1101221083 | Nyse
bristol myers squibbcompany stockchartcomparisonbmy
https://www.fool.com/investing/2020/05/07/3-reasons-bristol-myers-squibbs-revenue-skyrockete.aspx
The big drugmaker's blockbuster cancer immunotherapy Opdivo wasn't one of them.
bristol myers squibbreasonsrevenue